Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
---|
02/09/1999 | US5869471 Methods for the treatment of arthritis using phosphonates and NSAIDS |
02/09/1999 | US5869460 Sulfated and phosphated saccharide derivatives, process for the preparation of the same and use thereof |
02/09/1999 | US5869456 Use of glutathione diesters |
02/09/1999 | US5869455 Serine protease inhibitors-N-substituted derivatives |
02/09/1999 | US5869451 Activate the thrombopoietin receptor. |
02/09/1999 | US5869271 G-beta-gamma regulated phosphatidylinositol-3' kinase |
02/09/1999 | US5869270 Single chain MHC complexes and uses thereof |
02/09/1999 | US5869055 Anti-inflammatory CD14 polypeptides |
02/09/1999 | US5869050 Administering to patient antibody against b7 antigen and immunosuppressive agent in synergistic mixture; treatment of transplant rejection, graft versus host disease, rheumatoid arthritis |
02/08/1999 | CA2239222A1 Novel rpoa |
02/05/1999 | CA2239270A1 Novel phosphoribosyl transferase |
02/05/1999 | CA2238673A1 Novel aminopeptidase |
02/05/1999 | CA2212315A1 Pharmaceutical composition with neurotrophic-like biological activity |
02/04/1999 | WO1999005268A1 Production of erythropoietin by endogenous gene activation |
02/04/1999 | WO1999005175A2 Diagnosis and treatment of diseases using anti-anti-t-cell receptor vbeta anti-bodies or peptides which are recognized by said antibodies, and endocrine secretion regulatory protein i (esrp1) |
02/04/1999 | WO1999005171A1 NOVEL ESTROGEN RECEPTOR β AND ISOFORMS |
02/04/1999 | WO1999005170A1 NOVEL ESTROGEN β RECEPTOR AND ISOFORMS |
02/04/1999 | WO1999005147A1 Thiazolobenzoheterocycles, preparation and medicines containing same |
02/04/1999 | WO1999005144A1 Novel compounds |
02/04/1999 | WO1999005143A1 Novel compounds |
02/04/1999 | WO1999005142A1 Novel compounds |
02/04/1999 | WO1999005135A1 Polyophenol compounds and drugs containing the same |
02/04/1999 | WO1999005134A1 Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
02/04/1999 | WO1999005132A1 Benzothia(oxa)diazol derivatives and their use as endothelin-receptor antagonists |
02/04/1999 | WO1999005131A1 1,3-diaza- heterocycles and their use as nitric oxide synthase inhibitors |
02/04/1999 | WO1999005113A1 Substituted 6-phenylphenanthridines |
02/04/1999 | WO1999005112A1 Substituted 6-alkylphenanthridines |
02/04/1999 | WO1999005111A1 Novel tetrazole derivatives |
02/04/1999 | WO1999005107A1 Vitronectin receptor antagonist |
02/04/1999 | WO1999005104A1 Indole compounds as cox-2 inhibitors |
02/04/1999 | WO1999005096A2 Urokinase inhibitors |
02/04/1999 | WO1999004795A1 Delta opioid receptor agonist for reducing ischemic damage |
02/04/1999 | WO1999004794A1 Cyclic amine modulators of chemokine receptor activity |
02/04/1999 | WO1999004782A1 Therapeutic and dietary compositions containing essential fatty acids and bioactive disulphides |
02/04/1999 | WO1999004780A1 Therapeutic or prophylactic agent for glomerulopathy |
02/04/1999 | WO1999004776A1 Antitumor agents |
02/04/1999 | WO1999004775A2 Method of treating dopaminergic and gaba-nergic disorders |
02/04/1999 | WO1999004773A2 Method for inhibiting bone resorption |
02/04/1999 | WO1999004770A2 A pharmaceutical composition active in reducing production of mcp-1 protein |
02/04/1999 | WO1999004752A2 Methods for treating skin pigmentation |
02/04/1999 | WO1999004628A1 Phototherapy based method for treating pathogens and composition for effecting same |
02/04/1999 | WO1998051337A3 Immunogenic compositions to the cck-b/gastrin-receptor and methods for the treatment of tumors |
02/04/1999 | WO1998050424A3 Human serine protease precursor |
02/04/1999 | WO1998050419A3 4-aza-steroids as inhibitors of testosterone-5-alpha-reductase |
02/04/1999 | WO1998050016A3 Intravaginal drug delivery devices for the administration of testosterone and testosterone precursors |
02/04/1999 | CA2298526A1 Phototherapy based method for treating pathogens and composition for effecting same |
02/04/1999 | CA2298053A1 Novel estrogen receptor .beta. and isoforms |
02/04/1999 | CA2298015A1 Production of erythropoietin by endogenous gene activation |
02/04/1999 | CA2297923A1 Novel tetrazole-substituted 6-phenyl-pheanathridines as pde inhibitors |
02/04/1999 | CA2297910A1 Vitronectin receptor antagonist |
02/04/1999 | CA2297907A1 Human estrogen receptor beta |
02/04/1999 | CA2297410A1 Method of treating dopaminergic and gaba-nergic disorders |
02/04/1999 | CA2297315A1 Endothelin receptor antagonists |
02/04/1999 | CA2297251A1 Delta opioid receptor agonist for reducing ischemic damage |
02/04/1999 | CA2297166A1 1,3-diaza- heterocycles and their use as nitric oxide synthase inhibitors |
02/04/1999 | CA2296648A1 Novel compounds |
02/04/1999 | CA2296518A1 Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
02/04/1999 | CA2296478A1 Antitumor agents |
02/04/1999 | CA2296426A1 Novel compounds |
02/04/1999 | CA2296314A1 Cyclic amine modulators of chemokine receptor activity |
02/04/1999 | CA2294300A1 Urokinase inhibitors |
02/04/1999 | CA2267077A1 Methods for treating skin pigmentation |
02/04/1999 | CA2239267A1 Novel compounds |
02/03/1999 | EP0894863A1 A YAK-1 related serine/threonine protein kinase-HTLAR33 |
02/03/1999 | EP0894862A2 Novel CysS |
02/03/1999 | EP0894861A2 Glycogen phosphorylase from Streptococcus pneumoniae |
02/03/1999 | EP0894859A2 Asparaginyl tRNA synthetase from Streptococcus pneumoniae |
02/03/1999 | EP0894858A2 Prolyl tRNA synthetase from Streptococcus pneumoniae |
02/03/1999 | EP0894857A2 SecA gene from Streptococcus pneumoniae |
02/03/1999 | EP0894855A2 Human I kappa B-beta transcription factor |
02/03/1999 | EP0894854A2 A novel splicing variant of the epstein-barr virus-induced g-protein coupled receptor |
02/03/1999 | EP0894806A1 Novel pheS |
02/03/1999 | EP0894796A1 Imidazolines substituted with a heterocyclic ring as alpha-2 antagonists |
02/03/1999 | EP0894795A1 Benzimidazole, benzoxazole and benzothiazole derivatives, their preparation and pharmaceutical compositions containing them |
02/03/1999 | EP0894789A1 Substituted indole-2-carboxylic acids as glucosyl transferase inhibitors |
02/03/1999 | EP0894494A2 Cell renewal rate compositions |
02/03/1999 | EP0894137A1 Novel human myeloid terminal differentiation response gene |
02/03/1999 | EP0894130A1 Modulators of tnf receptor associated factor (traf), their preparation and use |
02/03/1999 | EP0894089A1 Novel heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them |
02/03/1999 | EP0894088A1 Substituted sulfonic acid n- (aminoiminomethyl)phenylalkyl]-azaheterocyclamide compounds |
02/03/1999 | EP0894085A1 Benzyl(idene)-lactam derivatives, their preparation and their use as selective (ant)agonists of 5-ht1a- and/or 5-ht1d receptors |
02/03/1999 | EP0894003A1 N-formyl hydroxylamine containing compounds useful as ace inhibitors and/or nep inhibitors |
02/03/1999 | EP0894001A1 Inhibitor of immunoglobulin e antibody production |
02/03/1999 | EP0893996A1 Use of rapamycin derivatives in vasculopathies and xenotransplantation |
02/03/1999 | EP0893995A1 Anticachectic composition |
02/03/1999 | EP0793649B1 18,19-dinor-vitamin d compounds |
02/03/1999 | EP0786996A4 Cysteine protease and serine protease inhibitors |
02/03/1999 | EP0729352B1 Interdigitation-fusion liposomes containing arachidonic acid metabolites |
02/03/1999 | EP0510186B1 Therapeutic uses of melanin |
02/03/1999 | CN1207131A Recombinant fusion proteins to growth hormone and serum albumin |
02/03/1999 | CN1207100A Novel indole-2,3-done-3-oxime derivatives |
02/03/1999 | CN1207097A Novel substituted 4-(1H-benzimidazol-2-YL) [1,4] diazepanes useful for the treatment of allergic diseases |
02/03/1999 | CN1207047A Cartilage/bone inducing materials for reparation |
02/03/1999 | CN1206712A Heterocyclic compound, preparation process thereof and medicinal composition containing same |
02/03/1999 | CN1206600A Multi-effect nutrient health care medicinal liquor prescription for old and middle-aged people and preparation process thereof |
02/03/1999 | CN1206589A Process for preparing medicine composition |
02/03/1999 | CN1041939C Androstenones |
02/03/1999 | CN1041938C Triterpene derivatives and endothelin-receptor antagonists containing the same |
02/03/1999 | CN1041929C Heterocyclic derivatives and preparation process and use thereof, medicinal composition containing same |
02/03/1999 | CN1041923C Piperzine derivatives and preparation process and usage thereof |